The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease

BMC Nephrology

Alberto Martinez-Castelao¹  Pedro Aranda¹  Vicente Alvarez-Chivas²  Florencio García¹  Fernando de Alvaro¹  Esther Rubio²  Jose Luis Gorriz¹  José Portolés² 

[1] Spanish Group for the study of Diabetic Nephropathy, GEENDIAB-SEN, Barcelona, Spain;Spanish Renal Research Network, REDInRen Red 6/0016 (Instituto Salud Carlos III), Madrid, Spain

关键词: Epidemiology;    Non-dialysis CKD patients;    Cardiovascular risk;    Anemia;    Chronic kidney disease;   

Others  :  1083036
DOI  :  10.1186/1471-2369-14-2

 received in 2012-03-20, accepted in 2012-12-20,  发布年份 2013

【 摘 要 】

Background

Anemia is a common condition in CKD that has been identified as a cardiovascular (CV) risk factor in end-stage renal disease, constituting a predictor of low survival. The aim of this study was to define the onset of anemia of renal origin and its association with the evolution of kidney disease and clinical outcomes in stage 3 CKD (CKD-3).

Methods

This epidemiological, prospective, multicenter, 3-year study included 439 CKD-3 patients. The origin of nephropathy and comorbidity (Charlson score: 3.2) were recorded. The clinical characteristics of patients that developed anemia according to EBPG guidelines were compared with those that did not, followed by multivariate logistic regression, Kaplan-Meier curves and ROC curves to investigate factors associated with the development of renal anemia.

Results

During the 36-month follow-up period, 50% reached CKD-4 or 5, and approximately 35% were diagnosed with anemia (85% of renal origin). The probability of developing renal anemia was 0.12, 0.20 and 0.25 at 1, 2 and 3 years, respectively. Patients that developed anemia were mainly men (72% anemic vs. 69% non-anemic). The mean age was 68 vs. 65.5 years and baseline proteinuria was 0.94 vs. 0.62 g/24h (anemic vs. non anemic, respectively). Baseline MDRD values were 36 vs. 40 mL/min and albumin 4.1 vs. 4.3 g/dL; reduction in MDRD was greater in those that developed anemia (6.8 vs. 1.6 mL/min/1.73 m²/3 years). These patients progressed earlier to CKD-4 or 5 (18 vs. 28 months), with a higher proportion of hospitalizations (31 vs. 16%), major CV events (16 vs. 7%), and higher mortality (10 vs. 6.6%) than those without anemia. Multivariate logistic regression indicated a significant association between baseline hemoglobin (OR=0.35; 95% CI: 0.24-0.28), glomerular filtration rate (OR=0.96; 95% CI: 0.93-0.99), female (OR=0.19; 95% CI: 0.10-0.40) and the development of renal anemia.

Conclusions

Renal anemia is associated with a more rapid evolution to CKD-4, and a higher risk of CV events and hospitalization in non-dialysis-dependent CKD patients. This suggests that special attention should be paid to anemic CKD-3 patients.

【 授权许可】

   
2013 Portoles et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, Li S, Wang C, Collins AJ, Bakris GL: Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009, 53(4 Suppl 4):S11-S21.
• [2]Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2004, 13(1):73-81.
• [3]Otero A, de Francisco A, Gayoso P, Garcia F: Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia 2010, 30(1):78-86.
• [4]ERA/EDTA: Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Anaemia evaluation. Nephrol Dial Transplant 2004, 19(Suppl. 2):ii2-ii5.
• [5]Stancu S, Barsan L, Stanciu A, Mircescu G: Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? Clin J Am Soc Nephrol 2010, 5(3):409-416.
• [6]Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ: Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol 2011, 7(3):166-176.
• [7]Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y: Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 2009, 24(7):2117-2123.
• [8]Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 2002, 162(12):1401-1408.
• [9]Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005, 16(1):180-188.
• [10]Shaheen FA, Souqiyyeh MZ, Al-Attar BA, Karkar A, Al Jazairi AM, Badawi LS, Ballut OM, Hakami AH, Naguib M, Al-Homrany MA: Prevalence of anemia in predialysis chronic kidney disease patients. Saudi J Kidney Dis Transpl 2011, 22(3):456-463.
• [11]Singh AK: The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol 2010, 5(4):553-556.
• [12]Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47(11):1245-1251.
• [13]Akizawa T, Makino H, Matsuo S, Watanabe T, Imai E, Nitta K, Ohashi Y, Hishida A: Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol 2011, 15(2):248-257.
• [14]Portoles J, Castelao AM, Gorriz JL, Tato AM, de Alvaro F: Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease. Ren Fail 2009, 31(10):869-875.
• [15]Del Fabbro P, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B: Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol 2010, 11:27. BioMed Central Full Text
• [16]Anderson J, Glynn LG, Newell J, Iglesias AA, Reddan D, Murphy AW: The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study. BMC Cardiovasc Disord 2009, 9:51. BioMed Central Full Text
• [17]Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA: Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009, 4(1):48-56.
• [18]Atkinson MA, Martz K, Warady BA, Neu AM: Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol 2010, 25(9):1699-1706.
• [19]Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E: The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis. Med Pregl 2007, 60(Suppl 2):33-38.
• [20]Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, Goligorsky MS, Singh AK: Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol 2011, 75(6):524-533.
• [21]Levin A: Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 2002, 80:35-38.
• [22]De Nicola L, Minutolo R, Chiodini P, Zamboli P, Cianciaruso B, Nappi F, Signoriello S, Conte G, Zoccali C, Group S-TCS: Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: a prospective cohort study in outpatient renal clinics. Am J Nephrol 2010, 32(6):533-540.
• [23]Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A: Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010, 14(6):558-570.
• [24]Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004, 19(1):121-132.
• [25]McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 2004, 20(9):1501-1510.
• [26]Portoles J, Lopez-Gomez JM, Aljama P: A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Nephrol Dial Transplant 2007, 22(2):500-507.